PE firm Advent acquires 50.1% stake in Suven Pharma at Rs 495/share, to make open offer for additional 26% stake 29 09/2023 by admin-suven
Cabinet okays FDI of up to Rs 9,589 crore for 76.1% stake in Hyderabad-based Suven Pharma 29 09/2023 by admin-suven
Casper Pharma Receives EIR from USFDA for its PAI (pre-approval inspection) 10 10/202204 10/2022 by admin-suven